Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy.
COVID-19 vaccine
Italy
SARS-CoV-2 Alpha variant
SARS-CoV-2 Delta variant
epidemiology
hospitalization
surveillance
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
18 Nov 2021
18 Nov 2021
Historique:
received:
28
10
2021
revised:
12
11
2021
accepted:
17
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Differences in the demographic and clinical characteristics of patients infected with the Alpha and Delta SARS-CoV-2 variants of concern in a large region of Southern Italy were assessed. Two cohorts of positive patients were compared. The Alpha group consisted of 11,135 subjects diagnosed between 21 March and 21 April 2021, and the Delta group consisted of 499 positive subjects diagnosed between 21 July and 21 August 2021. A descriptive and statistical analysis of the demographic and clinical characteristics of the two groups was performed. The proportion of patients with mild and moderate infections was significantly higher in the Delta than in the Alpha group (
Identifiants
pubmed: 34835285
pii: vaccines9111354
doi: 10.3390/vaccines9111354
pmc: PMC8624869
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet. 2021 Jun 26;397(10293):2461-2462
pubmed: 34139198
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1249-1254
pubmed: 34499628
Int J Environ Res Public Health. 2021 Apr 29;18(9):
pubmed: 33947087
Lancet. 2021 Jul 31;398(10298):385-387
pubmed: 34274038
Euro Surveill. 2021 Jul;26(26):
pubmed: 34212838
Nat Med. 2021 Jul;27(7):1131-1133
pubmed: 34045737
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
JAMA. 2021 Sep 21;326(11):1001-1002
pubmed: 34406361
Microorganisms. 2021 Jul 20;9(7):
pubmed: 34361977
Euro Surveill. 2021 Sep;26(35):
pubmed: 34477054
Viruses. 2021 Apr 29;13(5):
pubmed: 33946747
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
BMJ. 2020 Dec 16;371:m4857
pubmed: 33328153
Lancet Infect Dis. 2021 Aug 27;:
pubmed: 34461056
Microbiol Resour Announc. 2021 Jan 28;10(4):
pubmed: 33509997
Lancet. 2021 Oct 16;398(10309):1407-1416
pubmed: 34619098
Nature. 2021 Jul;595(7865):17-18
pubmed: 34158664
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Cell. 2021 Aug 5;184(16):4220-4236.e13
pubmed: 34242578
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
Clin Infect Dis. 2021 Aug 23;:
pubmed: 34423834
Wellcome Open Res. 2021 May 19;6:121
pubmed: 34095513
Lancet. 2021 Nov 13;398(10313):1825-1835
pubmed: 34717829